Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 8,530 RLAY shares, $161.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Relay Therapeutics, Inc. (RLAY) | Sale | 8,530 | $161.8K |
| Jul 30, 2026 | Relay Therapeutics, Inc. (RLAY) | Sale | 2,237 | $41.6K |
| Jul 8, 2026 | Relay Therapeutics, Inc. (RLAY) | Sale | 8,660 | $162.0K |
| Jun 24, 2026 | Relay Therapeutics, Inc. (RLAY) | Exercise/Conversion | 93,456 | $385.0K |
| Apr 30, 2026 | Relay Therapeutics, Inc. (RLAY) | Sale | 1,490 | $22.0K |
| Jan 29, 2026 | Relay Therapeutics, Inc. (RLAY) | Sale | 18,895 | $144.0K |
| Jan 15, 2026 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 575,000 | n/a |
| Oct 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 30,897 | $225.2K |
| Jul 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 4,069 | $15.2K |
| Apr 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 4,090 | $13.0K |